Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
WVE-006 by GSK for Alpha-1 Antitrypsin Deficiency (A1AD): Likelihood of Approval
WVE-006 is under clinical development by GSK and currently in Phase II for Alpha-1 Antitrypsin Deficiency (A1AD). According to GlobalData,...